<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528813</url>
  </required_header>
  <id_info>
    <org_study_id>HUB-UnB OnychoLASER</org_study_id>
    <nct_id>NCT01528813</nct_id>
  </id_info>
  <brief_title>Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis</brief_title>
  <official_title>AVALIAÇÃO DO USO DO LASER ERBIUM-DOPED YTTRIUM ALUMINIUM GARNET (Er:YAG) ASSOCIADO AO ESMALTE DE AMOROLFINA NO TRATAMENTO DA ONICOMICOSE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brasilia University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brasilia University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the effectiveness of a single application of Er:YAG laser to
      the nail plate in increasing the efficacy of the amorolfine lacquer used in the treatment of
      onychomycosis (fungal infection of nails) cause by dermatophyte molds. This clinical trial
      respective involve 30 subjects with hands or feet distal-lateral subungual onychomycosis (a
      kind of onychomycosis that does not affect the ungual matrix). The patients will receive
      treatment for 6 months meanwhile they will be followed up to access efficacy of the treatment
      by means of the clearance of nail plate infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a trial study involving 30 subjects with onychomycosis of hands or feet. The patient
      must have at least 2 injured nails as each affected nail will receive a different treatment -
      self-controlled study design.

      Therefore, each nail out of two from a single patient will be randomized into the following
      study arms:

      Group A of nails - will receive only weekly application of amorolfine lacquer for a total of
      6 months.

      Group B of nails - will receive a single application of Er:YAG laser followed by weekly
      application of amorolfine lacquer for a total of 6 months.

      At the end of 6 months the data from both groups, A and B, regarding *clinical cure,
      *mycological cure and *extent of damage to the nail plates will be analyzed using specific
      tests.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extent of nail plate damage</measure>
    <time_frame>6 months</time_frame>
    <description>At the beginning and after 6 months of treatment both the group, A and B, will have the length from nail cuticle to the closest point of damage to the nail plate measured by a millimeter scale. It will later be accessed to determine the clearance rate of the nail plate achieved with each treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mycological cure</measure>
    <time_frame>6 months</time_frame>
    <description>After 6 months of treatment both the group, A and B, will be accessed by direct mycological examination and culture to evaluate mycological cure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical cure</measure>
    <time_frame>6 months</time_frame>
    <description>After 6 months of treatment both the group, A and B, will be accessed by dermatological examination to evaluate clinical cure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Onychomycosis</condition>
  <arm_group>
    <arm_group_label>Er:YAG + amorolfine lacquer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 ungual units affected by onychomycosis due to dermatophytes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amorolfine lacquer</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>30 ungual units affected by onychomycosis due to dermatophytes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Er:YAG laser + amorolfine lacquer</intervention_name>
    <description>To each compromised ungual unit randomly assigned to this group it will be applied a single session of Er:YAG laser to the ungual lamina in the beginning of study. Onwards, amorolfine lacquer will be applied weekly for a period of 06 months.</description>
    <arm_group_label>Er:YAG + amorolfine lacquer</arm_group_label>
    <other_name>Loceryl</other_name>
    <other_name>Er:YAG laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amorolfine lacquer</intervention_name>
    <description>To each compromised ungual unit randomly assigned to this group, it will be applied amorolfine lacquer weekly for a period of 06 months.</description>
    <arm_group_label>Amorolfine lacquer</arm_group_label>
    <other_name>Loceryl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19-60 year-old

          -  preserved cognitive status

          -  direct mycological examination or culture showing infection of hands or feet nails by
             dermatophyte molds

        Exclusion Criteria:

          -  diabetes type 1 or 2; peripheral vascular disease

          -  having undergone any treatment in the last 6 months

          -  peripheral nerve disorders (e.g. peripheral neuropathy, Hansen's disease, etc)

          -  willing to paint nail during the study

          -  high blood pressure

          -  use of any immunosuppressive drugs; congenital or acquired immunodeficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orlando O Morais, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Brasilia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orlando O Morais, Investigator</last_name>
    <phone>+55(61)9916-2339</phone>
    <email>orlando.unb@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Brasilia</name>
      <address>
        <city>Brasilia</city>
        <state>Federal District</state>
        <zip>70910-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orlando O Morais, M.D.</last_name>
      <phone>+55(61)99162339</phone>
      <email>orlando.unb@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Orlando O Morais, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2012</study_first_submitted>
  <study_first_submitted_qc>February 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>August 5, 2013</last_update_submitted>
  <last_update_submitted_qc>August 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brasilia University Hospital</investigator_affiliation>
    <investigator_full_name>Izelda Maria Carvalho Costa</investigator_full_name>
    <investigator_title>Adjunct Professor</investigator_title>
  </responsible_party>
  <keyword>Erbium-doped yttrium aluminium garnet laser</keyword>
  <keyword>Er:YAG</keyword>
  <keyword>Amorolfine lacquer</keyword>
  <keyword>Dermatophytes</keyword>
  <keyword>Subungual distal lateral onychomycosis</keyword>
  <keyword>Drug delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Onychomycosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amorolfine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

